Collegium Pharmaceutical
COLL
Cars.com
CARS
Halozyme Therapeutics
HALO
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
OC Owens-Corning
- 144.085
- +0.125+0.09%
Trading Apr 29 12:38 ET
12.33BMarket Cap19.55P/E (TTM)
144.305High142.170Low179.19KVolume143.130Open143.960Pre Close25.67MTurnover0.21%Turnover Ratio19.55P/E (Static)85.54MShares212.65052wk High2.43P/B12.23BFloat Cap123.40552wk Low2.49Dividend TTM84.86MShs Float212.650Historical High1.73%Div YieldTTM1.48%Amplitude4.273Historical Low143.282Avg Price1Lot Size
Owens-Corning Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 13.41%10.98B | 23.26%2.84B | 22.87%3.05B | 8.82%2.79B | -1.33%2.3B | -0.86%9.68B | 0.83%2.3B | -1.98%2.48B | -1.46%2.56B | -0.64%2.33B |
| Operating revenue | 13.41%10.98B | 23.26%2.84B | 22.87%3.05B | 8.82%2.79B | -1.33%2.3B | -0.86%9.68B | 0.83%2.3B | -1.98%2.48B | -1.46%2.56B | -0.64%2.33B |
| Cost of revenue | 10.39%7.72B | 20.84%2.04B | 22.03%2.14B | 6.13%1.92B | -7.00%1.62B | -2.11%6.99B | -1.52%1.69B | -4.58%1.75B | -3.00%1.81B | 0.87%1.74B |
| Gross profit | 21.28%3.25B | 29.92%799M | 24.90%908M | 15.29%867M | 15.45%680M | 2.56%2.68B | 7.89%615M | 4.91%727M | 2.45%752M | -4.85%589M |
| Operating expense | 46.51%1.55B | 63.29%467M | 50.57%399M | 54.72%410M | 13.52%277M | 2.71%1.06B | -26.85%286M | 23.26%265M | 7.29%265M | 36.31%244M |
| Selling and administrative expenses | 25.63%1.04B | 38.81%304M | 38.81%279M | 20.29%249M | 3.92%212M | 3.49%831M | 0.92%219M | 0.00%201M | 2.99%207M | 10.87%204M |
| Research and development costs | 17.07%144M | 13.16%43M | 24.14%36M | 21.43%34M | 10.71%31M | 16.04%123M | 15.15%38M | 11.54%29M | 16.67%28M | 21.74%28M |
| Other operating expenses | 244.34%365M | 313.79%120M | 140.00%84M | 323.33%127M | 183.33%34M | -13.82%106M | -79.43%29M | 391.67%35M | 36.36%30M | 142.86%12M |
| Operating profit | 4.81%1.7B | 0.91%332M | 10.17%509M | -6.16%457M | 16.81%403M | 2.46%1.62B | 83.80%329M | -3.35%462M | 0.00%487M | -21.59%345M |
| Net non-operating interest income expense | -178.95%-212M | -335.71%-61M | -311.76%-70M | -178.26%-64M | 22.73%-17M | 30.28%-76M | 48.15%-14M | 39.29%-17M | 11.54%-23M | 21.43%-22M |
| Non-operating interest expense | 178.95%212M | 335.71%61M | 311.76%70M | 178.26%64M | -22.73%17M | -30.28%76M | -48.15%14M | -39.29%17M | -11.54%23M | -21.43%22M |
| Other net income (expense) | -1,402.27%-573M | -293.15%-574M | 1M | -68.35%44M | -4,966.67%-146M | -99.24%1M | 9,350.00%189M | |||
| Earnings from equity interest | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Special income (charges) | -403.70%-574M | ---574M | --0 | --0 | --0 | --189M | --0 | --0 | --0 | --189M |
| -Less:Impairment of capital assets | --483M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Gain on sale of business | ---91M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Gain on sale of property,plant,equipment | --0 | --0 | --0 | --0 | --0 | --189M | --0 | --0 | --0 | --189M |
| Other non- operating income (expenses) | 100.69%1M | --0 | ---- | --1M | ---- | -1,711.11%-145M | -4,966.67%-146M | -50.00%1M | ---- | ---- |
| Income before tax | -42.43%916M | -279.29%-303M | -1.57%439M | -15.09%394M | -24.61%386M | -1.43%1.59B | 9.03%169M | -23.37%446M | 0.22%464M | 23.67%512M |
| Income tax | -31.42%275M | -207.50%-43M | 9.09%120M | -9.09%110M | -32.31%88M | 7.51%401M | 21.21%40M | -3.51%110M | 1.68%121M | 21.50%130M |
| Earnings from equity interest net of tax | 100.00%6M | 100.00%2M | 100.00%2M | 100.00%2M | ---- | --3M | --1M | 0.00%1M | 200.00%1M | ---- |
| Net income | -45.77%647M | -298.46%-258M | -4.75%321M | -16.86%286M | -21.99%298M | -3.87%1.19B | 6.56%130M | -28.14%337M | 0.29%344M | 24.43%382M |
| Net income continuous Operations | -45.77%647M | -298.46%-258M | -4.75%321M | -16.86%286M | -21.99%298M | -3.87%1.19B | 6.56%130M | -28.14%337M | 0.29%344M | 24.43%382M |
| Minority interest income | 0 | 0 | 0 | 200.00%1M | 0.00%-1M | -3M | 50.00%-1M | 0 | -1M | -133.33%-1M |
| Net income attributable to the parent company | -45.90%647M | -296.95%-258M | -4.75%321M | -17.39%285M | -21.93%299M | -3.63%1.2B | 5.65%131M | -28.30%337M | 0.58%345M | 25.99%383M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -45.90%647M | -296.95%-258M | -4.75%321M | -17.39%285M | -21.93%299M | -3.63%1.2B | 5.65%131M | -28.30%337M | 0.58%345M | 25.99%383M |
| Basic earnings per share | -43.86%7.45 | -302.70%-3 | -1.34%3.69 | -14.17%3.27 | -18.38%3.42 | 3.27%13.27 | 11.28%1.48 | -23.36%3.74 | 8.55%3.81 | 36.93%4.19 |
| Diluted earnings per share | -43.91%7.37 | -305.48%-3 | -1.62%3.65 | -14.29%3.24 | -18.47%3.4 | 3.46%13.14 | 10.61%1.46 | -23.35%3.71 | 8.31%3.78 | 37.62%4.17 |
| Dividend per share | 15.28%2.49 | 15.18%1.29 | 15.38%0.6 | 0 | 15.38%0.6 | 37.58%2.16 | 28.74%1.12 | 48.57%0.52 | 0 | 48.57%0.52 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call